cromakalim has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Duan, L; Hu, G; Huang, X; Qian, X; Xie, J | 1 |
| Kang, S; Kim, DK; Shin, DS; Yi, M; You, S; Zhang, X; Zhao, J | 1 |
2 other study(ies) available for cromakalim and cytochrome c-t
| Article | Year |
|---|---|
K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cells, Cultured; Cromakalim; Cytochromes c; Diazoxide; Dopamine; KATP Channels; Membrane Transport Modulators; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Pinacidil; Potassium Channels, Inwardly Rectifying; Reactive Oxygen Species | 2010 |
A novel cromakalim analogue induces cell cycle arrest and apoptosis in human cervical carcinoma HeLa cells through the caspase- and mitochondria-dependent pathway.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cromakalim; Cytochromes c; DNA Damage; DNA Replication; Female; HeLa Cells; Humans; Mitochondria; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2 | 2011 |